Putnam Investments’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-15,080
Closed -$2.77M 849
2021
Q2
$2.77M Sell
15,080
-268
-2% -$49.2K ﹤0.01% 655
2021
Q1
$2.35M Sell
15,348
-54,070
-78% -$8.27M ﹤0.01% 659
2020
Q4
$10.8M Buy
69,418
+9,696
+16% +$1.51M 0.02% 357
2020
Q3
$6.83M Sell
59,722
-118
-0.2% -$13.5K 0.01% 411
2020
Q2
$6.72M Buy
59,840
+1,146
+2% +$129K 0.01% 411
2020
Q1
$5.27M Buy
58,694
+56,617
+2,726% +$5.08M 0.01% 431
2019
Q4
$225K Hold
2,077
﹤0.01% 858
2019
Q3
$203K Hold
2,077
﹤0.01% 874
2019
Q2
$272K Hold
2,077
﹤0.01% 846
2019
Q1
$281K Sell
2,077
-28
-1% -$3.79K ﹤0.01% 836
2018
Q4
$205K Sell
2,105
-1,100,872
-100% -$107M ﹤0.01% 918
2018
Q3
$153M Sell
1,102,977
-57,882
-5% -$8.05M 0.33% 91
2018
Q2
$144M Buy
1,160,859
+428,033
+58% +$53.1M 0.33% 96
2018
Q1
$81.7M Buy
732,826
+729,505
+21,966% +$81.3M 0.19% 130
2017
Q4
$397K Sell
3,321
-700
-17% -$83.7K ﹤0.01% 980
2017
Q3
$564K Sell
4,021
-361
-8% -$50.6K ﹤0.01% 980
2017
Q2
$533K Sell
4,382
-943,739
-100% -$115M ﹤0.01% 975
2017
Q1
$115M Buy
948,121
+943,330
+19,690% +$114M 0.27% 103
2016
Q4
$586K Sell
4,791
-9
-0.2% -$1.1K ﹤0.01% 1103
2016
Q3
$588K Buy
4,800
+100
+2% +$12.3K ﹤0.01% 1103
2016
Q2
$549K Hold
4,700
﹤0.01% 1184
2016
Q1
$654K Hold
4,700
﹤0.01% 1191
2015
Q4
$897K Hold
4,700
﹤0.01% 1181
2015
Q3
$735K Sell
4,700
-400
-8% -$62.6K ﹤0.01% 1240
2015
Q2
$922K Buy
5,100
+300
+6% +$54.2K ﹤0.01% 1234
2015
Q1
$832K Buy
4,800
+300
+7% +$52K ﹤0.01% 1232
2014
Q4
$833K Sell
4,500
-3,300
-42% -$611K ﹤0.01% 1210
2014
Q3
$1.29M Hold
7,800
﹤0.01% 1154
2014
Q2
$1.22M Hold
7,800
﹤0.01% 1144
2014
Q1
$1.19M Hold
7,800
﹤0.01% 1164
2013
Q4
$1.04M Buy
7,800
+484
+7% +$64.3K ﹤0.01% 1193
2013
Q3
$850K Buy
7,316
+16
+0.2% +$1.86K ﹤0.01% 1245
2013
Q2
$673K Buy
+7,300
New +$673K ﹤0.01% 1274